{"disease":{"id":"resectable-clear-cell-carcinoma-of-the-kidney","name":"resectable clear cell carcinoma of the kidney"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06574412","title":"Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcinoma.","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"The First Hospital of Jilin University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}